Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 9 studies | 33% ± 9% | |
astrocyte | 9 studies | 31% ± 15% | |
epithelial cell | 6 studies | 23% ± 8% | |
GABAergic neuron | 6 studies | 39% ± 21% | |
oligodendrocyte | 6 studies | 28% ± 5% | |
endothelial cell | 5 studies | 26% ± 6% | |
glutamatergic neuron | 5 studies | 44% ± 24% | |
cardiac muscle cell | 5 studies | 40% ± 11% | |
fibroblast | 4 studies | 20% ± 7% | |
oligodendrocyte precursor cell | 4 studies | 35% ± 8% | |
interneuron | 4 studies | 40% ± 19% | |
amacrine cell | 3 studies | 23% ± 8% | |
hepatocyte | 3 studies | 40% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2216.16 | 459 / 459 | 100% | 18.01 | 1118 / 1118 |
esophagus | 100% | 2159.90 | 1445 / 1445 | 100% | 15.88 | 183 / 183 |
kidney | 100% | 2069.38 | 89 / 89 | 100% | 23.86 | 901 / 901 |
liver | 100% | 5654.97 | 226 / 226 | 100% | 29.47 | 406 / 406 |
intestine | 100% | 2328.39 | 966 / 966 | 100% | 13.46 | 525 / 527 |
bladder | 100% | 1427.00 | 21 / 21 | 100% | 12.02 | 502 / 504 |
prostate | 100% | 1287.13 | 244 / 245 | 100% | 18.79 | 502 / 502 |
uterus | 100% | 1334.55 | 170 / 170 | 100% | 12.84 | 457 / 459 |
thymus | 100% | 1523.22 | 651 / 653 | 100% | 13.20 | 603 / 605 |
stomach | 100% | 1908.42 | 359 / 359 | 99% | 13.34 | 284 / 286 |
adrenal gland | 100% | 4388.73 | 258 / 258 | 99% | 17.51 | 228 / 230 |
brain | 99% | 1348.54 | 2608 / 2642 | 100% | 14.89 | 705 / 705 |
lung | 99% | 1196.19 | 570 / 578 | 100% | 11.77 | 1155 / 1155 |
pancreas | 99% | 1126.15 | 325 / 328 | 99% | 13.28 | 176 / 178 |
skin | 100% | 2028.19 | 1808 / 1809 | 97% | 11.77 | 457 / 472 |
ovary | 100% | 1348.63 | 180 / 180 | 97% | 6.98 | 416 / 430 |
adipose | 100% | 2535.57 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.11 | 29 / 29 |
muscle | 100% | 5069.85 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1291.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.82 | 45 / 45 |
blood vessel | 100% | 1425.36 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 6144.20 | 836 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 7.19 | 67 / 80 |
peripheral blood | 57% | 596.67 | 529 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0022900 | Biological process | electron transport chain |
GO_0006979 | Biological process | response to oxidative stress |
GO_0022904 | Biological process | respiratory electron transport chain |
GO_0033539 | Biological process | fatty acid beta-oxidation using acyl-CoA dehydrogenase |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0048039 | Molecular function | ubiquinone binding |
GO_0004174 | Molecular function | electron-transferring-flavoprotein dehydrogenase activity |
GO_0016491 | Molecular function | oxidoreductase activity |
GO_0048038 | Molecular function | quinone binding |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0005515 | Molecular function | protein binding |
GO_0051539 | Molecular function | 4 iron, 4 sulfur cluster binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0009055 | Molecular function | electron transfer activity |
Gene name | ETFDH |
Protein name | Mutant electron-transferring flavoprotein dehydrogenase Electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO) (EC 1.5.5.1) Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase) Electron transfer flavoprotein dehydrogenase |
Synonyms | hCG_1811923 |
Description | FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . FUNCTION: Accepts electrons from ETF and reduces ubiquinone. . |
Accessions | ENST00000684641.1 ENST00000683478.1 A0A804HI80 A0A804HJK8 ENST00000683305.1 ENST00000684622.1 A0A804HKB8 ENST00000684675.1 A7UNU5 A0A804HI48 A0A804HI70 A0A804HK08 ENST00000683448.1 A0A804HK05 A0A804HKY7 ENST00000683079.1 ENST00000683081.1 ENST00000684552.1 A0A804HI73 ENST00000682456.1 ENST00000684296.1 ENST00000682734.1 A0A804HL84 ENST00000684036.1 Q547S8 B4DEQ0 Q16134 ENST00000307738.5 [Q16134-3] ENST00000684505.1 ENST00000683004.1 ENST00000684129.1 A7UNU6 A0A804HJT7 ENST00000683751.1 ENST00000684627.1 ENST00000683483.1 A0A804HL81 ENST00000682345.1 ENST00000511912.6 [Q16134-1] A0A804HK66 |